| Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children. | |
| | |
MedLine Citation:
|
PMID: 21212419 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND AND OBJECTIVES: Acute kidney injury (AKI) in hospitalized children results in increased patient morbidity and mortality. Nephrotoxic-medication exposure is a common cause of AKI. Currently, no data exist to quantify the risks of developing AKI for various nephrotoxic medications in children. The primary aim of the current study is to assess for a potential association between nephrotoxic medications and the risk of developing AKI in hospitalized noncritically ill children with no pre-existing renal insufficiency. Design, SETTING, PARTICIPANTS, & MEASUREMENTS: We performed a retrospective case-control study in pediatric hospitalized noncritically ill patients aged 1 day to 18 years. The cases were patients who developed AKI, as defined by the pediatric modified RIFLE (pRIFLE) criteria; patients without AKI served as controls and were matched by age category, gender, and disease state. RESULTS: 561/1660 (33.8%) patients identified for inclusion had AKI (441 category "R," 117 category "I," three category "F"); 357 cases were matched with 357 controls. Patients with AKI had longer length of hospital stay and increased hospital costs. Patients with AKI had exposure to more nephrotoxic medications for a longer period of time compared with controls. Odds of exposure for at least one nephrotoxic medication was significant for development of AKI. Exposure to more nephrotoxic medications was associated with an increased risk of AKI. CONCLUSIONS: Increasing exposure to three or more nephrotoxic medications places pediatric patients at greater risk of acute kidney injury with resultant increased hospital costs and patient morbidity. |
| | |
Authors:
|
Brady S Moffett; Stuart L Goldstein |
Related Documents
:
|
21123409 - Medication adherence and hospitalization among patients with schizophrenia treated with... 21186439 - Performance of state medical boards: implications for hospitals and health systems. 21371389 - Evaluation of sexual health medicine teaching at medical schools in australia and new z... 21320239 - Development and psychometric evaluation of the german version of the medication regimen... 21206419 - Pharmacist's role in an interdisciplinary falls clinic. 21522019 - Applying surveillance and screening to family psychosocial issues: implications for the... 21735949 - Physicians' medication prescribing in primary care . in riyadh city, saudi arabia. lite... 21696279 - Amee 2010 symposium: medical student education in the twenty-first century - a new flex... 15062499 - The emergency department medical director as supervisor of medical professionals. |
Publication Detail:
|
Type: Journal Article Date: 2011-01-06 |
Journal Detail:
|
Title: Clinical journal of the American Society of Nephrology : CJASN Volume: 6 ISSN: 1555-905X ISO Abbreviation: Clin J Am Soc Nephrol Publication Date: 2011 Apr |
Date Detail:
|
Created Date: 2011-04-08 Completed Date: 2011-08-18 Revised Date: 2012-04-02 |
Medline Journal Info:
|
Nlm Unique ID: 101271570 Medline TA: Clin J Am Soc Nephrol Country: United States |
Other Details:
|
Languages: eng Pagination: 856-63 Citation Subset: IM |
Copyright Information:
|
© 2011 by the American Society of Nephrology |
Affiliation:
|
Texas Children's Hospital, Department of Pharmacy, 6621 Fannin Street, MC 2-2510, Houston, TX 77030, USA. bsmoffet@texaschildrens.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Kidney Injury
/
chemically induced* Adolescent Age Factors Case-Control Studies Child Child, Preschool Creatinine / blood Female Humans Infant Infant, Newborn Kidney / drug effects* Logistic Models Male Retrospective Studies |
| Chemical | |
Reg. No./Substance:
|
60-27-5/Creatinine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: RON KINASE TRANS-PHOSPHORYLATION SUSTAINS MET ONCOGENE ADDICTION.
Next Document: Primary care-specialist collaboration in the care of patients with chronic kidney disease.